Nashville, TENNESSEE1 Active Studies

Myeloproliferative Neoplasms Clinical Trials in Nashville, TENNESSEE

Find 1 actively recruiting myeloproliferative neoplasms clinical trials in Nashville, TENNESSEE. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
62
Enrolling

Recruiting Myeloproliferative Neoplasms Studies in Nashville

About Myeloproliferative Neoplasms Clinical Trials in Nashville

Myeloproliferative neoplasms (MPNs) are blood cancers in which the bone marrow overproduces red blood cells, platelets, or white blood cells. Types include polycythemia vera, essential thrombocythemia, and myelofibrosis. Treatment depends on the specific type and risk factors.

There are currently 1 myeloproliferative neoplasms clinical trials recruiting participants in Nashville, TENNESSEE. These studies are seeking a combined 62 participants. Research is being sponsored by National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.

Myeloproliferative Neoplasms Clinical Trials in Nashville — FAQ

Are there myeloproliferative neoplasms clinical trials in Nashville?

Yes, there are 1 myeloproliferative neoplasms clinical trials currently recruiting in Nashville, TENNESSEE. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Nashville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Nashville research site will contact you about next steps.

Are clinical trials in Nashville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Nashville studies also compensate for your time and travel.

What myeloproliferative neoplasms treatments are being tested?

The 1 active trials in Nashville are testing new therapies including novel drugs, biologics, and treatment approaches for myeloproliferative neoplasms.

Data updated March 2, 2026 from ClinicalTrials.gov